CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
+14.72%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$329M
AUM Growth
-$47.2M
(-13%)
Cap. Flow
-$69.7M
Cap. Flow
% of AUM
-21.15%
Top 10 Holdings %
Top 10 Hldgs %
86.21%
Holding
30
New
7
Increased
6
Reduced
8
Closed
5
Top Buys
| 1 |
SLRN
ACELYRIN
SLRN
|
$55.7M |
| 2 |
Keros Therapeutics
KROS
|
$5.67M |
| 3 |
Disc Medicine
IRON
|
$5.56M |
| 4 |
Direxion Daily S&P Biotech Bear 3X Shares
LABD
|
$4.67M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$3.92M |
Top Sells
Sector Composition
| 1 | Healthcare | 98.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Kezar Life Sciences
KZR
$28.5M
| – | – |
-68,945
| Closed | -$2.16M |
|
27
Entrada Therapeutics
TRDA
$202M
| – | – |
-56,374
| Closed | -$817K |
|
|
KDNY
28
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-135,000
| Closed | -$3.13M |
|
|
ONCR
29
DELISTED
Oncorus, Inc.
ONCR
| – | – |
-2,367,436
| Closed | -$815K |
|
|
RXDX
30
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-934,135
| Closed | -$100M |
|